4-biarylyl-1-phenylazetidin-2-ones

4-biarylyl-1-phenylazetidin-2-ones

Abstract

4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed.
L'invention concerne des 4-Biarylyl-1-phénylazétidin-2-ones utilisés dans le traitement de l'hypercholestérolémie.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (2)

    Publication numberPublication dateAssigneeTitle
    US-2005209165-A1September 22, 2005Eduardo Martinez, Talley John J, Stephen Antonelli, Barden Timothy C, Regina Lundrigan-Soucy, Schairer Wayne C, Jing-Jing Yang, Zimmer Daniel P4-Biarylyl-1-phenylazetidin-2-ones
    WO-2005021497-A2March 10, 2005Microbia, Inc.Trimeres et dimeres fixes de 1,4-diphenylazetidin-2-ones

NO-Patent Citations (0)

    Title

Cited By (16)

    Publication numberPublication dateAssigneeTitle
    CN-102370648-AMarch 14, 2012山东新时代药业有限公司一种药物组合物及其用途
    EP-2995317-A1March 16, 2016Satiogen Pharmaceuticals, Inc.Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
    US-7863265-B2January 04, 2011Astrazeneca Ab2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
    US-7906502-B2March 15, 2011Astrazeneca Ab2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
    US-8541581-B2September 24, 2013Infinity Pharmaceuticals, Inc.Inhibitors of fatty acid amide hydrolase
    US-9066936-B2June 30, 2015Takeda Pharmaceutical Company LimitedSolid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent
    US-9169238-B2October 27, 2015Takeda Pharmaceutical Company LimitedSolid pharmaceutical composition
    WO-2007136696-A2November 29, 2007Schering CorporationUtilisation d'azétidinones substituées pour le traitement de la sitostérolémie
    WO-2007136696-A3March 20, 2008Harry R Davis Jr, Schering CorpUse of substituted azetidinone compounds with cetp inhibitors for the treatment of sitosterolemia
    WO-2008061238-A2May 22, 2008Ironwood Pharmaceuticals, Inc.Procédés de production de 4-biphénylylazétidin-2-ones
    WO-2008061238-A3September 25, 2008Ironwood Pharmaceuticals Inc, John J Talley, Timothy C BardenProcédés de production de 4-biphénylylazétidin-2-ones
    WO-2008108486-A1September 12, 2008Teijin Pharma LimitedDérivés de 1-biarylazétidinone
    WO-2008123536-A1October 16, 2008Takeda Pharmaceutical Company LimitedSolid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
    WO-2013063526-A1May 02, 2013Lumena Pharmaceuticals, Inc.Inhibiteurs du recyclage de l'acide biliaire pour traitement de l'hypercholémie et de la maladie cholestatique hépatique
    WO-2014144485-A1September 18, 2014Lumena Pharmaceuticals, Inc.Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
    WO-2014144650-A2September 18, 2014Lumena Pharmaceuticals, Inc.Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease